Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: A potential role in the emergence of multidrug-resistance

Journal of the Formosan Medical Association

Volumn 110, Issue 6, 2011, Pages 372-381

  Chang, Jenn Tyang ^a,b   Dou, Horng Yunn ^b   Yen, Chia Liang ^a   Wu, Ying Hsun ^b   Huang, Ruay Ming ^b   Lin, Huey Juan ^b   Su, Ih Jen ^b   Shieh, Chi Chang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Beijing strain; Diabetes mellitus; Multidrug resistant tuberculosis; Pulmonary tuberculosis; Spoligotype analysis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL STRAIN; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; TAIWAN; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79960352923     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60055-7     Document Type: Article

References (34)

1. Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
2. Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006;100:415-31.
3. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
4. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on anti-tuberculosis drug resistance surveillance. N Engl J Med 1998;338:1641-9.
5. Shah NS, Wright A, Bai GH, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007;13:380-7.
6. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006;368:2142-54.
7. Espinal MA, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on anti-tuberculosis drug resistance surveillance. N Engl J Med 2001;344:1294-303.
8. Jabbar A, Hussain SF, Khan AA. Clinical characteristics of pulmonary tuberculosis in adult Pakistani patients with coexisting diabetes mellitus. East Mediterr Health J 2006;12: 522-7.
9. Kim SJ, Hong YP, Lew WJ, et al. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76: 529-33.
10. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007;45:436-8.
11. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
12. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8.
13. Mboussa J, Monabeka H, Kombo M, et al. Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 2003; 59:39-44.
14. Bashar M, Alcabes P, Rom WN, et al. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001; 120:1514-9.
15. Bacakoglu F, Basoglu OK, Cok G, et al. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001; 68:595-600.
16. Nissapatorn V, Kuppusamy I, Jamaiah I, et al. Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J. Trop Med Public Health 2005;36:213-20.
17. Singla R, Khan N, Al Sharif N, et al. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006;10:74-9.
18. Fiorenza G, Rateni L, Farroni MA, et al. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett 2005; 98:45-8.
19. American Thoracic Society. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 2000;161:1376-95.
20. World Health Organization. Global tuberculosis control. WHO report 1999. Geneva, Switzerland: World Health Organization, 1999.
21. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: World Health Organization, 2006. WHO/HTM/TB/2006.361.
22. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpoIDB4) for classification, population genetics and epidemiology. BMC Microbil 2006;6:23.
23. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45:428-35.
24. Hsueh PR, Liu YC, So J, et al. Mycobacterium tuberculosis in Taiwan. J Infect 2006;52:77-85.
25. Stead WW, Kerby GR, Schlueter DP, et al. The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis. Ann Intern Med 1968;68:731-45.
26. Wang CS, Yang CJ, Chen HC, et al. Impact of type 2 diabetes on manifestation and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009;137:203-10.
27. Wu YC, Hsu GJ, Chung KY, et al. Intervals before tuberculosis diagnosis and isolation at a regional hospital in Taiwan. J Formos Med Assoc 2007;106:1007-12.
28. Fujino T, Hasegawa N, Satou R, et al. Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results. Kekkaku 1998;73:471-6.
29. Jou R, Chiang CY, Huang WL. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin microbiol 2005;43:95-100.
30. Dou HY, Tseng FC, Lin CW, et al. Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis 2008;8:170.
31. Park YK, Shin S, Ryu S, et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbil Methods 2005;63:165-72.
32. Jou R, Chen HY, Chiang CY, et al. Genetic diversity of multiple-drug resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J Clin Microbiol 2005;43:1390-4.
33. Nijland HM, Ruslami R, Stalenhoef JE, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 2006;43:848-54.
34. Tsukaguchi K, Okamura H, Matsuzawa K, et al. Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus. Kekkaku 2002;77:409-13.